Mouse Anti-CES1 Recombinant Antibody (A106) (CBMAB-AP11706LY)

Na, K., Kim, M., Kim, C. Y., Lim, J. S., Cho, J. Y., Shin, H., ... & Paik, Y. K. (2020). Potential Regulatory Role of Human-Carboxylesterase-1 Glycosylation in Liver Cancer Cell Growth. Journal of Proteome Research, 19(12), 4867-4883.

Her, L., & Zhu, H. J. (2020). Carboxylesterase 1 and precision pharmacotherapy: pharmacogenetics and nongenetic regulators. Drug Metabolism and Disposition, 48(3), 230-244.

Xu, Y., Zhu, Y., Bawa, F. C., Hu, S., Pan, X., Yin, L., & Zhang, Y. (2020). Hepatocyte‐Specific Expression of Human Carboxylesterase 1 Attenuates Diet‐Induced Steatohepatitis and Hyperlipidemia in Mice. Hepatology communications, 4(4), 527-539.

Wang, X., Shi, J., & Zhu, H. J. (2019). Functional study of carboxylesterase 1 protein isoforms. Proteomics, 19(4), 1800288.

Ding, L., Tian, Z., Hou, J., Dou, T., Jin, Q., Wang, D., ... & Ge, G. (2019). Sensing carboxylesterase 1 in living systems by a practical and isoform-specific fluorescent probe. Chinese Chemical Letters, 30(3), 558-562.

Tian, Z., Ding, L., Li, K., Song, Y., Dou, T., Hou, J., ... & Cui, J. (2019). Rational design of a long-wavelength fluorescent probe for highly selective sensing of carboxylesterase 1 in living systems. Analytical chemistry, 91(9), 5638-5645.

Qian, Y., Wang, X., & Markowitz, J. S. (2019). In vitro inhibition of carboxylesterase 1 by major cannabinoids and selected metabolites. Drug Metabolism and Disposition, 47(5), 465-472.

Neuvonen, M., Tarkiainen, E. K., Tornio, A., Hirvensalo, P., Tapaninen, T., Paile‐Hyvärinen, M., ... & Niemi, M. (2018). Effects of genetic variants on carboxylesterase 1 gene expression, and clopidogrel pharmacokinetics and antiplatelet effects. Basic & clinical pharmacology & toxicology, 122(3), 341-345.

Xu, J., Xu, Y., Xu, Y., Yin, L., & Zhang, Y. (2017). Global inactivation of carboxylesterase 1 (Ces1/Ces1g) protects against atherosclerosis in Ldlr−/− mice. Scientific reports, 7(1), 1-12.

Wang, X., Rida, N., Shi, J., Wu, A. H., Bleske, B. E., & Zhu, H. J. (2017). A comprehensive functional assessment of carboxylesterase 1 nonsynonymous polymorphisms. Drug Metabolism and Disposition, 45(11), 1149-1155.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols